EXHIBIT 99.4
EMPLOYMENT AGREEMENT
THIS EMPLOYMENT AGREEMENT (the "Agreement"), is entered into as of December 21,
2004 by and between Critical Therapeutics, Inc., a Delaware corporation with its
principal place of business at ▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ (the
"Company"), and ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇, residing at ▇▇▇ ▇▇▇▇▇▇▇ ▇▇., ▇▇▇▇▇▇▇, ▇▇
▇▇▇▇▇ (the "Executive").
WHEREAS, the Company desires to employ the Executive, and the Executive desires
to be employed by the Company.
In consideration of the mutual covenants and promises contained herein, and
other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged by the parties hereto, the parties agree as follows:
1. TERM OF EMPLOYMENT. The Company hereby agrees to employ the Executive,
and the Executive hereby accepts employment with the Company, upon the terms set
forth in this Agreement, for the period commencing on January 1, 2005 (the
"Commencement Date") and ending on December 31, 2007 (the "Initial Term") unless
renewed or sooner terminated in accordance with the provisions of this Section 1
or Section 4 respectively. Upon each subsequent anniversary of the Commencement
Date, the term of this Agreement shall automatically extend for an additional
year (such period, including the Initial Term and as it may be extended, the
"Employment Period") unless (i) either the Company or the Executive gives at
least ninety (90) days notice of non-renewal prior to such anniversary or (ii)
the Agreement is terminated in accordance with the provisions of Section 4.
2. TITLE; CAPACITY. The Executive shall serve as Senior Vice President of
Sales and Marketing or in such other position as the Company or its Board of
Directors (the "Board") may determine from time to time. The Executive shall be
based at the Company's office in Lexington, MA. The Executive shall be subject
to the supervision of, and shall have such authority as is delegated to him by,
the Chief Executive Officer of the Company or his designee.
The Executive hereby accepts such employment and agrees to undertake the
duties and responsibilities inherent in such position and such other duties and
responsibilities as the Board or its designee shall from time to time reasonably
assign to him. The Executive agrees to devote his entire business time,
attention and energies to the business and interests of the Company during the
Employment Period; provided, however, that the Executive may serve as a
consultant or a member of an advisory board or a board of directors with the
prior consent of the Board. The Executive agrees to abide by any rules,
regulations, instructions, personnel practices and policies of the Company that
are applicable to him and any changes therein that may be adopted from time to
time by the Company.
3. COMPENSATION AND BENEFITS.
3.1. Salary. The Company shall pay the Executive a base salary in
semi-monthly installments at an annualized rate of $233,300, less lawful
deductions. Such salary shall be subject to adjustment thereafter as determined
by the Board.
3.2. Annual Maximum Cash Bonus. The Executive shall be eligible to
receive an annual Maximum Cash Bonus of twenty-five (25) percent of his then
annual base salary ("Maximum Cash Bonus"). The Compensation Committee of the
Board shall determine the amount of the actual award, if any, based on overall
corporate performance and individual performance. Actual awards may be greater
than or less than the Executive's Maximum Cash Bonus, depending in part upon the
extent to which actual performance exceeds or falls below the performance goals.
Any bonus shall be paid in a single lump sum, subject to lawful deductions, at
such time as bonuses are regularly paid to senior executives of the Company.
Each cash bonus award that may become payable shall be paid solely from the
general assets of the Company.
3.3. Annual Equity Awards. The Executive shall be eligible to
receive annual equity awards. The Compensation Committee of the Board shall
determine the amount of the actual equity award, if any, based on overall
corporate performance and individual performance.
3.4. Fringe Benefits. The Executive shall be entitled to participate
in all bonus and benefit programs that the Company establishes and makes
available to its employees or executives, if any, to the extent that the
Executive's position, tenure, salary, age, health and other qualifications make
him eligible to participate; provided, however, the Executive shall not be
eligible to participate in the Company's Cash Bonus Program for Employees (Other
than Executive Officers). The Executive shall be entitled to three (3) weeks of
paid vacation per year, accrued at a rate of 1.25 days per month until the
Executive has completed four (4) years of service at which time vacation shall
accrue at 1.67 days per month (four (4) weeks per year), and, if requested in
writing by the Chief Executive Officer, such vacation time shall be taken at
such times as may be approved by the Chief Executive Officer or his designee.
3.5. Reimbursement of Expenses. The Company shall reimburse the
Executive for all reasonable travel, entertainment and other expenses incurred
or paid by the Executive in connection with, or related to, the performance of
his duties, responsibilities or services under this Agreement, upon presentation
by the Executive of documentation, expense statements, vouchers and/or such
other supporting information as the Company may request, provided, however, that
the amount available for such travel, entertainment and other expenses may be
fixed in advance by the Board.
4. EMPLOYMENT TERMINATION. The employment of the Executive by the Company
pursuant to this Agreement shall terminate upon the occurrence of any of the
following:
4.1. Expiration of the Employment Period in accordance with Section
1;
4.2. At the election of the Company, for Cause (as defined in
Section 21), immediately upon written notice by the Company to the Executive;
4.3. At the election of the Executive, for Good Reason (as defined
in Section 21), immediately upon written notice by the Executive to the Company;
4.4. At the election of the Company without Cause during a Change of
Control Period (as defined in Section 21) or at the election of the Executive
for Good Reason during a
- 2 -
Change of Control Period;
4.5. Thirty (30) days after the death or disability (as defined in
Section 21) of the Executive;
4.6. At the election of the Executive by providing written notice to
the Company; and
4.7. At the election of the Company, without Cause, by providing
written notice to the Executive.
5. EFFECT OF TERMINATION.
5.1. Termination for Cause. In the event the Executive's employment
is terminated for Cause pursuant to Section 4.2, the Company shall pay to the
Executive the compensation and benefits otherwise payable to him under Section 3
through the last day of his actual employment by the Company.
5.2. Termination at the Election of the Executive. In the event the
Executive elects to terminate his employment pursuant to Section 4.6, the
Company shall pay the Executive the compensation and benefits otherwise payable
to him under Section 3 through the last day of his actual employment by the
Company. If the Executive provides ninety (90) days prior written notice, the
Executive shall receive an amount equal to a pro rata payment (as defined in
Section 21) of the annual cash bonus, if any, paid to the Executive in the year
prior to his resignation, subject to the Executive's execution of a severance
agreement and release drafted by and satisfactory to counsel for the Company. No
other benefits are payable upon the Executive's voluntary resignation unless for
Good Reason.
5.3. Termination for Death or Disability. If the Executive's
employment is terminated by death or because of disability pursuant to Section
4.5, the Company shall pay to the estate of the Executive or to the Executive,
as the case may be, the compensation that would otherwise be payable to the
Executive up to the end of the month in which the termination of his employment
because of death or disability occurs. In addition, if the Executive's
employment terminates by death or because of a disability, the vesting of his
outstanding unvested stock options and restricted stock shall accelerate by one
year. If the Executive's employment terminates as a result of his death, the
Executive's estate shall also receive an amount equal to a pro rata payment of
the annual cash bonus, if any, paid to the Executive in the year prior to his
death, subject to the Executive's estate's execution of a release drafted by and
satisfactory to counsel for the Company.
5.4. Termination Without Cause or for Good Reason and not during a
Change in Control Period. If the Executive's employment is terminated without
Cause pursuant to Section 4.7, or for Good Reason pursuant to Section 4.3 and
such termination does not occur during a Change of Control Period, the Company
shall:
- 3 -
(i) pay the Executive, in accordance with the Company's regular payroll
practices, a lump sum payment equal to one (1) times his annualized
base salary, less lawful deductions;
(ii) pay the Executive on a monthly basis an amount equal to (a) eighty
(80) percent of the Executive's monthly health and dental COBRA
premiums for the Executive and his dependents, if any, if the
Executive properly elects to continue health and dental insurance
under COBRA and (b) one hundred (100) percent of the cost of the
monthly premiums paid by the Company for life insurance and
disability insurance for the Executive in the month preceding the
Executive's termination of employment, such payments under
subsections (a) and (b) to continue until the earlier of twelve (12)
months after the termination of the Executive's employment or until
the last day of the first month that the Executive is eligible for
other employer-sponsored health coverage;
(iii) pay the Executive a pro rata payment of the Maximum Cash Bonus for
which he was eligible, less lawful deductions; and
(iv) accelerate vesting of fifty (50) percent of all of the Executive's
outstanding unvested stock options and restricted stock;
all such payments subject to the Executive's execution of a severance
agreement and release drafted by and satisfactory to counsel for the
Company.
5.5. Termination Without Cause or for Good Reason during a Change in
Control Period. If the Executive's employment is terminated without Cause
pursuant to Section 4.7, or for Good Reason pursuant to Section 4.3 and such
termination occurs during a Change of Control Period, the Company shall:
(i) pay the Executive, in accordance with the Company's regular payroll
practices, a lump sum payment equal to one (1) times his annualized
base salary, less lawful deductions;
(ii) pay the Executive on a monthly basis an amount equal to (a) eighty
(80) percent of the Executive's monthly health and dental COBRA
premiums for the Executive and his dependents, if any, if the
Executive properly elects to continue health and dental insurance
under COBRA and (b) one hundred (100) percent of the cost of the
monthly premiums paid by the Company for life insurance and
disability insurance for the Executive in the month preceding the
Executive's termination of employment, such payments under
subsections (a) and (b) to continue until the earlier of twelve (12)
months after the termination of the Executive's employment or until
the last day of the first month that the Executive is eligible for
other employer-sponsored health coverage;
(iii) pay the Executive a pro rata payment of the Maximum Cash Bonus for
which he was eligible, less lawful deductions;
- 4 -
(iv) accelerate vesting of one hundred (100) percent of all of the
Executive's outstanding unvested stock options and restricted stock;
and
(v) provide the Executive with up to three (3) months of outplacement
services as arranged for by the Company,
all such payments subject to the Executive's execution of a severance
agreement and release drafted by and satisfactory to counsel for the
Company.
6. VESTING OF STOCK UPON A CHANGE OF CONTROL. Fifty (50) percent of the
Executive's outstanding unvested stock options and restricted stock will vest on
a Change of Control (as defined in Section 21).
7. NON-COMPETE.
(a) During the Employment Period and for a period of one (1) year
after the termination or expiration of the Executive's employment for any reason
or after a Change in Control, the Executive will not directly or indirectly:
(i) as an individual proprietor, partner, stockholder,
officer, employee, director, joint venturer, investor, lender, or in any other
capacity whatsoever (other than as the holder of not more than one percent (1%)
of the total outstanding stock of a publicly held company), engage in the
business of providing services or developing, producing, marketing or selling
products competitive with the services provided or products being developed,
produced, marketed or sold by the Company while the Executive was employed by
the Company; or
(ii) either alone or in association with others, recruit,
solicit, induce, hire or engage as an independent contractor or attempt to
recruit, solicit, induce, hire or engage as an independent contractor, any
person who then is or was employed by the Company except for an individual whose
employment with the Company has been terminated (X) by the employee for any
reason other than Good Reason for a period of six (6) months or longer, (Y) by
the Company for any reason, or (Z) by the employee for Good Reason.
(iii) either alone or in association with others, solicit,
divert or take away, or attempt to solicit, divert or take away, the business or
patronage of any of the clients, customers or accounts, or prospective clients,
customers or accounts, of the Company which were contacted, solicited or served
by the Executive while employed by the Company.
(b) The Executive agrees that, if requested by the Company in
writing, he will give notice to the Company of each new business activity he
plans to undertake during the non-competition period, at least ten (10) business
days prior to beginning any such activity. The notice shall state the name and
address of the individual, corporation, association or other entity or
organization ("Entity") for whom such activity is undertaken and the name of the
Executive's business relationship or position with the entity. The Executive
further agrees to provide the Company with other pertinent information
concerning such business activity as the Company
- 5 -
may reasonably request in order to determine the Executive's continued
compliance with his obligations under this Agreement. The Executive agrees that,
if requested by the Company in writing, he will provide a copy of Section 7 and
8 of this Agreement to all persons and Entities with whom he seeks to be hired
or do business before accepting employment or engagement with any of them.
(c) If any restriction set forth in this Section 7 is found by any
court of competent jurisdiction to be unenforceable because it extends for too
long a period of time or over too great a range of activities or in too broad a
geographic area, it shall be interpreted to extend only over the maximum period
of time, range of activities or geographic area as to which it may be
enforceable.
(d) The geographic scope of subsection 7(a) above shall extend to
anywhere the Company or any of its subsidiaries does business.
(e) The Executive acknowledges that the restrictions contained in
this Section are necessary for the protection of the business and goodwill of
the Company and in light of, among other things, the highly competitive market
in which the Company operates. The Executive agrees that any breach of this
Section will cause the Company substantial and irrevocable damage and therefore,
in the event of any such breach, in addition to such other remedies which may be
available, the Company shall have the right to seek specific performance and
injunctive relief without posting a bond.
(f) If the Executive violates the provisions of this Section, he
shall continue to be held by the restrictions set forth in this Section, until a
period equal to the period of restriction has expired without any violation.
8. PROPRIETARY INFORMATION AND DEVELOPMENTS.
8.1. Proprietary Information.
(a) The Executive agrees that all information and know-how, whether
or not in writing, of a private, secret or confidential nature concerning the
Company's business or financial affairs (collectively, "Proprietary
Information") is and shall be the exclusive property of the Company. By way of
illustration, but not limitation, Proprietary Information may include
inventions, products, processes, methods, techniques, formulas, compositions,
compounds, projects, developments, plans, research data, clinical data,
financial data, personnel data, computer programs, and customer and supplier
lists. Executive will not disclose any Proprietary Information to others outside
the Company or use the same for any unauthorized purposes without written
approval by an officer of the Company, either during or after his employment,
unless and until such Proprietary Information has become public knowledge
without fault by the Executive.
(b) The Executive agrees that all files, letters, memoranda,
reports, records, data, sketches, drawings, laboratory notebooks, program
listings, or other written, photographic, or other tangible material containing
Proprietary Information, whether created by the Executive or
- 6 -
others, which shall come into his custody or possession, shall be and are the
exclusive property of the Company to be used by the Executive only in the
performance of his duties for the Company.
(c) The Executive agrees that his obligation not to disclose or use
information, know-how and records of the types set forth in paragraphs (a) and
(b) above, also extends to such types of information, know-how, records and
tangible property of customers of the Company or suppliers to the Company or
other third parties who may have disclosed or entrusted the same to the Company
or to the Executive in the course of the Company's business.
8.2. Developments.
(a) The Executive will make full and prompt disclosure to the
Company of all inventions, improvements, discoveries, methods, developments,
software, and works of authorship, whether patentable or not, which are created,
made, conceived or reduced to practice by the Executive or under his direction
or jointly with others during his employment by the Company, whether or not
during normal working hours or on the premises of the Company (all of which are
collectively referred to in this Agreement as "Developments").
(b) The Executive agrees to assign and does hereby assign to the
Company (or any person or entity designated by the Company) all his right, title
and interest in and to all Developments and all related patents, patent
applications, copyrights and copyright applications.
(c) The Executive agrees to cooperate fully with the Company, both
during and after his employment with the Company, with respect to the
prosecution, procurement, maintenance and enforcement and/or defense of patents,
trademarks, copyrights, trade secrets and other means for protection of
proprietary information (both in the United States and foreign countries)
relating to Developments. Executive shall sign all papers, including, without
limitation, copyright applications, patent applications, declarations, oaths,
formal assignments, assignment of priority rights, and powers of attorney, which
the Company may deem necessary or desirable in order to protect its rights and
interests in any Development. The Executive shall further execute and deliver
all such instruments and take all other actions as in the opinion of the Company
and its counsel shall be appropriate to vest in the Company (or in such person
as the Company may specify) all right, title and interest in said patents,
trademarks, copyrights, trade secrets and other means of protecting proprietary
information in any Development.
(d) Whenever requested to do so by the Company, both during and
after his employment with the Company, and at the expense of the Company, the
Executive shall cooperate fully and assist in the Company in the defense or
prosecution of any claims or actions now in existence or which may be brought in
the future in connection with (i) any litigation commenced by the Company
against third parties, (ii) any litigation commenced by a third party against
the Company and (iii) any administrative hearing or administrative proceeding
involving the Company. The Executive's full cooperation in connection with any
claims, actions or administrative proceedings shall include, but not be limited
to, his being available to meet with the Company's counsel to prepare for trial,
discovery or an administrative hearing and to act as a
- 7 -
witness when requested by the Company at reasonable times designated by the
Company.
(e) The Executive hereby irrevocably appoints the Company to be his
attorney in fact and, in his name and on his behalf, to execute all such
instruments and take all other actions and generally to use his name for the
purpose of providing to the Company the full benefit of the provisions of this
Section 8 of the Agreement.
(f) The Executive hereby waives and quitclaims to the Company any
and all claims, of any nature, which the Executive now or may hereafter have for
infringement of any Development assigned hereunder to the Company.
(g) The Executive acknowledges and agrees that all original works of
authorship which are made by the Executive (solely or jointly with others)
within the scope of Executive's employment and which are protectable by
copyright are "works made for hire," as that term is defined in the United
States Copyright Act (17 U.S.C. Section 101).
8.3. Other Agreements. Other than as previously disclosed to the
Company by the Executive in writing, the Executive hereby represents that he is
not bound by the terms of any agreement with any previous employer or other
party to refrain from using or disclosing any trade secret or confidential or
proprietary information in the course of his employment with the Company or to
refrain from competing, directly or indirectly, with the business of such
previous employer or any other party. The Executive further represents that his
performance of all the terms of this Agreement and as an Executive of the
Company does not and will not breach any agreement to keep in confidence
proprietary information, knowledge or data acquired by him in confidence or in
trust prior to his employment with the Company.
9. OTHER SEVERANCE ARRANGEMENTS. The benefits under this Agreement will be
provided in lieu of benefits under any severance plan of the Company or under
the Executive's offer letter. The Executive acknowledges and agrees that the
acceleration of vesting of stock options and restricted stock under this
Agreement is in lieu of any acceleration of vesting of stock options and
restricted stock upon a change of control under the Company's current and any
future stock option plans, including but not limited to, the Company's 2000
Equity Incentive Plan, 2003 Stock Incentive Plan and 2004 Stock Incentive Plan,
each as amended from time to time.
10. MITIGATION. The Executive has no obligation to mitigate amounts
payable under the Agreement by seeking other employment.
11. NOTICES. All notices required or permitted under this Agreement shall
be in writing and shall be deemed effective upon personal delivery or upon
deposit in the United States Post Office, by registered or certified mail,
postage prepaid, addressed to the other party at the address shown above, or at
such other address or addresses as either party shall designate to the other in
accordance with this Section 11.
12. PRONOUNS. Whenever the context may require, any pronouns used in this
Agreement shall include the corresponding masculine, feminine or neuter forms,
and the singular
- 8 -
forms of nouns and pronouns shall include the plural, and vice versa.
13. ENTIRE AGREEMENT. This Agreement constitutes the entire agreement
between the parties and supersedes all prior agreements and understandings,
whether written or oral, relating to the subject matter of this Agreement.
14. AMENDMENT. This Agreement may be amended or modified only by a written
instrument executed by both the Company and the Executive.
15. GOVERNING LAW. This Agreement shall be construed as a sealed
instrument and interpreted and enforced in accordance with the laws of the
Commonwealth of Massachusetts without regard to conflict of laws provisions. Any
action, suit, or other legal proceeding which is commenced to resolve any matter
arising under or relating to any provision of this Agreement shall be commenced
only in a court of the Commonwealth of Massachusetts (or, if appropriate, a
federal court located within the Commonwealth of Massachusetts) and the Company
and the Executive each consents to the jurisdiction of such a court.
16. SUCCESSORS AND ASSIGNS. This Agreement shall be binding upon and inure
to the benefit of both parties and their respective successors and assigns,
including any corporation with which or into which the Company may be merged or
which may succeed to its assets or business, provided, however, that the
obligations of the Executive are personal and shall not be assigned by the
Executive.
17. LEGAL FEES. The Company will reimburse the Executive for all
reasonable legal fees incurred in enforcing or contesting the Agreement if the
Executive prevails on such claim or claims.
18. DISPUTE RESOLUTION. Any claim or controversy arising out of or
relating to this Agreement, or any breach thereof, or otherwise arising out of
or relating to the Executive's employment, compensation and benefits with the
Company or the termination thereof including any claim for discrimination under
any local, state or federal employment discrimination law, except as
specifically excluded herein, shall be settled by arbitration in the
Commonwealth of Massachusetts, administered by the American Arbitration
Association under its National Rules for the Resolution of Employment Disputes.
Any claim or controversy not submitted to arbitration in accordance with this
Section shall be waived, and thereafter, no arbitration panel or tribunal or
court shall have the power to rule or make any award on any such claim or
controversy. The award rendered in any arbitration proceeding held under this
Section 18 shall be final and binding, and judgment upon the award may be
entered in any court having jurisdiction thereof. Claims for workers'
compensation or unemployment compensation benefits are not covered by this
Section. Also not covered by this Section are claims by the Company or by the
Executive for temporary restraining orders or preliminary injunctions
("temporary equitable relief") in cases in which such temporary equitable relief
would be otherwise authorized by law, including but not limited to claims for
equitable relief arising out of a breach of Sections 7 and/or 8 of this
Agreement. BOTH THE COMPANY AND THE EXECUTIVE EXPRESSLY WAIVE ANY RIGHT THAT ANY
PARTY EITHER HAS OR MAY HAVE TO A JURY TRIAL OF ANY DISPUTE ARISING OUT OF OR IN
ANY WAY RELATED TO THE EXECUTIVE'S EMPLOYMENT WITH OR TERMINATION FROM THE
- 9 -
COMPANY. THE EXECUTIVE EXPRESSLY ACKNOWLEDGES AND AGREES THAT HE HEREBY WAIVES
ANY RIGHT TO CLAIM OR RECOVER PUNITIVE DAMAGES.
19. ACKNOWLEDGMENT. THE EXECUTIVE STATES THAT HE HAS HAD A REASONABLE
PERIOD SUFFICIENT TO STUDY, UNDERSTAND AND CONSIDER THIS AGREEMENT, THAT HE HAS
HAD AN OPPORTUNITY TO CONSULT WITH LEGAL COUNSEL OF HIS CHOICE, THAT HE HAS READ
THIS AGREEMENT AND UNDERSTANDS ALL OF ITS TERMS, THAT HE IS ENTERING INTO AND
SIGNING THIS AGREEMENT KNOWINGLY AND VOLUNTARILY, AND THAT IN DOING SO HE IS NOT
RELYING UPON ANY STATEMENTS OR REPRESENTATIONS BY THE COMPANY OR ITS AGENTS.
20. MISCELLANEOUS.
20.1. No delay or omission by the Company in exercising any right
under this Agreement shall operate as a waiver of that or any other right. A
waiver or consent given by the Company on any one occasion shall be effective
only in that instance and shall not be construed as a bar or waiver of any right
on any other occasion.
20.2. The captions of the sections of this Agreement are for
convenience of reference only and in no way define, limit or affect the scope or
substance of any section of this Agreement.
20.3. In case any provision of this Agreement shall be invalid,
illegal or otherwise unenforceable, the validity, legality and enforceability of
the remaining provisions shall in no way be affected or impaired thereby.
20.4. Nothing in this Agreement should be construed to create a
trust or to establish or evidence Executive's claim of any right to payment
other than as an unsecured general creditor with respect to any payment to which
Executive may be entitled.
20.5. The provisions of Sections 7 and 8 shall survive the
termination of this Agreement.
20.6. The Executive agrees, upon termination of his employment,
promptly to deliver to the Company all files, books, documents, notes, lab
books, memoranda, specifications, cells, storage media, including software,
computer disks or tapes, computer printouts, together will all copies thereof,
and other property prepared by or on behalf of the Company or purchased with
Company funds and to refrain from making, retaining or distributing copies
thereof.
21. DEFINITIONS.
21.1. For the purposes of this Agreement, "Cause" for termination
shall be deemed to exist upon (a) willful failure by the Executive, which
failure is not cured within thirty (30) days of written notice to the Executive
from the Company, to perform his material responsibilities to the Company; (b)
willful misconduct by the Executive that is materially
- 10 -
injurious to the Company; (c) a determination by the Company within thirty (30)
days of the Executive's resignation that discharge under clause "B" of the
definition of Cause was warranted; or (d) a material breach of Section 7 or 8 of
this Agreement by the Executive.
21.2. For purposes of this Agreement, a "Change of Control" shall
mean:
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act (as defined below))
(a "Person") of beneficial ownership of any capital stock of the Company if,
after such acquisition, such Person beneficially owns (within the meaning of
Rule 13d-3 promulgated under the Exchange Act) 50% or more of the combined
voting power of the then-outstanding securities of the Company entitled to vote
generally in the election of directors (the "Outstanding Company Voting
Securities"); provided, however, that for purposes of this subsection (a), the
following acquisitions shall not constitute a Change in Control Event: (A) any
acquisition directly from the Company or (B) any acquisition by any corporation
pursuant to a Business Combination (as defined below) which complies with
clauses (x) and (y) of subsection (c) of this definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board (or, if applicable, the Board of Directors of
a successor corporation to the Company), where the term "Continuing Director"
means at any date a member of the Board (x) who was a member of the Board on the
date of the initial adoption of the Employment Agreement by the Board or (y) who
was nominated or elected subsequent to such date by at least a majority of the
directors who were Continuing Directors at the time of such nomination or
election or whose election to the Board was recommended or endorsed by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election; provided, however, that there shall be excluded from
this clause (y) any individual whose initial assumption of office occurred as a
result of an actual or threatened election contest with respect to the election
or removal of directors or other actual or threatened solicitation of proxies or
consents, by or on behalf of a person other than the Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or share exchange involving the Company or a sale or other
disposition of all or substantially all of the assets of the Company (a
"Business Combination"), unless, immediately following such Business
Combination, each of the following two conditions is satisfied: (x) all or
substantially all of the individuals and entities who were the beneficial owners
of the Outstanding Company Voting Securities immediately prior to such Business
Combination beneficially own, directly or indirectly, more than 50% of the
combined voting power of the then-outstanding securities entitled to vote
generally in the election of directors, respectively, of the resulting or
acquiring corporation in such Business Combination (which shall include, without
limitation, a corporation which as a result of such transaction owns the Company
or substantially all of the Company's assets either directly or through one or
more subsidiaries) (such resulting or acquiring corporation is referred to
herein as the "Acquiring Corporation") in substantially the same proportions as
their ownership of the Outstanding Company Voting Securities immediately prior
to such Business Combination and (y) no Person (excluding any Executive benefit
plan (or related trust) maintained or sponsored by the Company or by the
Acquiring Corporation) beneficially owns, directly or indirectly, 50% or more of
the combined voting power of the then-
- 11 -
outstanding securities of such corporation entitled to vote generally in the
election of directors (except to the extent that such ownership existed prior to
the Business Combination); or
(d) the liquidation or dissolution of the Company.
21.3. For purposes of this Agreement, a "Change of Control Period"
shall consist of the period from three (3) months before until one (1) year
after the date on which a Change of Control occurs.
21.4. As used in this Agreement, the term "disability" shall mean
total and permanent disability or the inability of the Executive to perform the
services contemplated under this Agreement with reasonable accommodation as may
be required by State or Federal law, due to a physical or mental disability, for
a period of one hundred and eighty (180) days, whether or not consecutive,
during any 360-day period. A determination of disability shall be agreed upon by
a physician satisfactory to the Executive and a physician selected by the
Company, provided that if these physicians do not agree, the Executive and the
Company shall each select a physician and these two together shall select a
third physician, whose determination as to disability shall be binding on all
parties.
21.5. As used in this Agreement, the term "Exchange Act" shall mean
the Securities Exchange Act of 1934, as amended.
21.6. For purposes of this Agreement, "Good Reason" shall be deemed
to exist upon (a) any reduction in the annual base compensation payable to the
Executive (but exclusive of any Maximum Cash Bonus, annual equity award or other
similar cash bonus or equity plans for this purpose); (b) the relocation of the
place of business at which the Executive is principally located to a location
that is greater than thirty (30) miles from its current location; (c) the
failure of the Company to comply with a material term of this Agreement; or (d)
significant reduction in the Executive's duties, responsibilities or position.
21.7. For purposes of this Agreement, "pro rata payment" shall be
deemed to mean the calculation of a payment by the Company based on the
proportion of the calendar year completed, based on the nearest whole number of
months of Executive's employment (for illustrative purposes only, if Executive
was terminated without Cause by the Company on April 13th of a given year,
Executive would be entitled to 1/4 of his Maximum Cash Bonus for such year under
Section 5.4(iii)).
22. NON-DISPARAGEMENT. The Executive understands and agrees that as a
condition to him of the monetary consideration provided in connection with this
Agreement, during the term of the Agreement and for a period of two (2) years
after the termination of his employment with the Company for any reason, he
shall not make any false, disparaging or derogatory statements in public or
private to any person or media outlet regarding the Company or any of its
directors, officers, employees, agents, or representatives or the Company's
business affairs and financial condition.
- 12 -
[Remainder of this page is intentionally left blank]
- 13 -
SIGNATURE PAGE TO EMPLOYMENT AGREEMENT
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the
day and year set forth above.
CRITICAL THERAPEUTICS, INC.
By: /s/ ▇▇▇▇ ▇. ▇▇▇▇▇
----------------------------------------
Name: ▇▇▇▇ ▇. ▇▇▇▇▇, M.D.
Title: President and Chief Executive Officer
EXECUTIVE
/s/ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇
--------------------------------------------
▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇
- 14 -
